Model-informed Drug Development Intensive Interactive Courses

***This Course is only open to SIMCYP ACADEMIC RESEARCH LICENSE HOLDERS*** Simcyp Intensive 4-day PBPK Boot Camp for Students, July 21-24 2025 | ONLINE  This PBPK boot camp is an ideal way to enhance the continuous education of students conducting research in the areas of Discovery, Drug Metabolism and Pharmacokinetics (DMPK), Clinical Pharmacology, Pharmaceutical and Drug Development and, it will provide an excellent opportunity to develop skills and remain informed of the latest scientific advances using Simcyp Simulator as the state of the art PBPK modelling platform. This 4-day workshop will comprise of lectures delivered by leading experts in the fields of PBPK modelling and will cover some of the major topics in model-informed drug development in-depth. you will need:   a functional Simcyp Simulator V24 including active license Monday 21 July - Introduction to IVIVE linked PBPK modelling Tuesday 22 July - Incorporation of physiological variability in prediction of PK profiles Wednesday 23 July - PBPK modelling to predict drug-drug interactions (enzymes and transporters) Thursday 24 July - Office hour / Question & Answer Session Read more

August 4-5, 2025 |  Tokyo, Japan VENUE: TKP Garden City PREMIUM Shinagawa Takanawa 4th Floor​ LAPTOP: Delegates are required to bring a laptop computer, and will be provided with access to the Simcyp Simulator via Amazon Workspaces for the duration of the course.  COURSE MATERIAL: will be provided electronically via LearnUpon. No printed materials will be given out during the course. From Discovery to First-in-human (FIH) Using IVIVE-PBPK Modeling In this focused workshop you will use the dynamic models within the Simcyp Discovery Simulator to prioritise compounds for progress to the next stage of development using information available in early drug discovery. You will use information on clearance, absorption, tissue distribution and DDI liability to inform compound selection. Finally, from the originally large database, only a few compounds will be selected for FIH and the simulation results compared with available clinical data. The case studies will cover various elements of model development including absorption, distribution and elimination. Optimal in vitro and clinical data sets will be discussed. Participants will learn how to choose the most suitable models and also investigate the impact of various relevant assumptions on model performance. Requirements for regulatory submissions will also be discussed. It is assumed that the participants have some familiarity with the fundamentals of PBPK modeling and have hands-on experience. Read more

Simcyp Focused Workshop: Best Practice, August 6-7, 2025 | Tokyo, Japan VENUE: TKP Garden City PREMIUM Shinagawa Takanawa 4th Floor​ LAPTOP: Delegates are required to bring a laptop computer, and will be provided with access to the Simcyp Simulator via Amazon Workspaces for the duration of the course.  COURSE MATERIAL: will be provided electronically via LearnUpon. No printed materials will be given out during the course. It is assumed that the participants are familiar with the fundamentals of PBPK modeling and have hands-on experience. The main aim of this focused workshop is to demonstrate the application of best practices in developing PBPK models, and to indicate how to qualify and refine model performance. Various case studies, including some real-life examples, will be presented. The case studies will cover various elements of model development including DDIs, special populations, transporters, and different formulations. Optimal in vitro and clinical data sets will be discussed. Participants will learn how to choose the most suitable models and also investigate the impact of various relevant assumptions on model performance. Requirements for regulatory submissions will also be discussed. It is assumed that the participants are familiar with the fundamentals of PBPK modeling and have hands-on experience. Read more

September 29 - 3 October, 2025 | ONLINE From Discovery to First-in-human (FIH) Using IVIVE-PBPK Modeling In this focused workshop you will use the dynamic models within the Simcyp Discovery Simulator to prioritise compounds for progress to the next stage of development using information available in early drug discovery. You will use information on clearance, absorption, tissue distribution and DDI liability to inform compound selection. Finally, from the originally large database, only a few compounds will be selected for FIH and the simulation results compared with available clinical data. The case studies will cover various elements of model development including absorption, distribution and elimination. Optimal in vitro and clinical data sets will be discussed. Participants will learn how to choose the most suitable models and also investigate the impact of various relevant assumptions on model performance. Requirements for regulatory submissions will also be discussed. It is assumed that the participants have some familiarity with the fundamentals of PBPK modeling and have hands-on experience. Live Online Courses There are no refunds for Live Online courses.  Certara retains the right to cancel the course 30 calendar days before the first session, in which case participants will receive a full refund. Read more

September 29 - 3 October, 2025 | ONLINE Predicting and evaluating complex DDIs—application of the Simcyp Population-based Simulator to real-life cases. Live Online Courses There are no refunds for Live Online courses.  Certara retains the right to cancel the course 30 calendar days before the first session, in which case participants will receive a full refund. Read more

Certara UK Limited is running a Simcyp hands-on workshop discussing the changes to pharmacokinetics during pregnancy and the prediction of pharmacokinetics (including in the milk) during lactation. Population based Physiologically Based Pharmacokinetic (PBPK) approach will be utilized to describe the pharmacokinetics during pregnancy and lactation and to determine population variability. The major topics covered are: Maternal and fetal gestational age-dependent physiological changes Prediction of maternal and fetal drug pharmacokinetics Ways of incorporating ex vivo experimental data on transplacental kinetics within the PBPK model Handling gestational age-varying covariates during simulation Prediction of PK in breastfeeding mothers and milk exposure using lactation models Prediction of infant dose for breastfed infant This course will be run using the Amazon Workspaces in Cloud; please ensure you have access to a computer. Live Online Courses There are no refunds for Live Online courses.  Certara retains the right to cancel the course 30 calendar days before the first session, in which case participants will receive a full refund. Read more